Stifel Financial’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $596K | Sell |
9,138
-145
| -2% | -$9.46K | ﹤0.01% | 2667 |
|
|
2025
Q1 | $622K | Buy |
9,283
+859
| +10% | +$57.5K | ﹤0.01% | 2543 |
|
|
2024
Q4 | $466K | Buy |
8,424
+1,425
| +20% | +$78.8K | ﹤0.01% | 2718 |
|
|
2024
Q3 | $418K | Buy |
+6,999
| New | +$418K | ﹤0.01% | 2783 |
|
|
2020
Q1 | – | Sell |
-3,245
| Closed | -$201K | – | 2820 |
|
|
2019
Q4 | $201K | Buy |
3,245
+450
| +16% | +$27.9K | ﹤0.01% | 2770 |
|
|
2019
Q3 | $203K | Sell |
2,795
-126
| -4% | -$9.15K | ﹤0.01% | 2650 |
|
|
2019
Q2 | $242K | Sell |
2,921
-114
| -4% | -$9.45K | ﹤0.01% | 2614 |
|
|
2019
Q1 | $214K | Buy |
+3,035
| New | +$214K | ﹤0.01% | 2553 |
|
|
2018
Q4 | – | Sell |
-3,847
| Closed | -$217K | – | 2664 |
|
|
2018
Q3 | $217K | Buy |
3,847
+17
| +0.4% | +$959 | ﹤0.01% | 2540 |
|
|
2018
Q2 | $256K | Buy |
3,830
+164
| +4% | +$11K | ﹤0.01% | 2395 |
|
|
2018
Q1 | $215K | Buy |
+3,666
| New | +$215K | ﹤0.01% | 2436 |
|
|
2017
Q4 | – | Sell |
-6,703
| Closed | -$349K | – | 2650 |
|
|
2017
Q3 | $349K | Buy |
+6,703
| New | +$349K | ﹤0.01% | 2087 |
|